0.00Open2.40Pre Close0 Volume0 Open Interest17.50Strike Price0.00Turnover2716.62%IV0.86%PremiumMay 17, 2024Expiry Date2.23Intrinsic Value100Multiplier-2DDays to Expiry0.17Time Value100Contract SizeAmericanOptions Type0.7479Delta0.0740Gamma8.22Leverage Ratio-29.7492Theta0.0000Rho6.15Eff Leverage0.0005Vega
Kiniksa Pharmaceuticals Stock Discussion
$Regenxbio(RGNX.US)$ Phase 2
$Leap Therapeutics(LPTX.US)$ Phase 2
$4D Molecular Therapeutics(FDMT.US)$ Phase 2
$Adverum Biotechnologies(ADVM.US)$ Phase 2
$Denali Therapeutics(DNLI.US)$ Phase 2
$EyePoint Pharmaceuticals(EYPT.US)$ Phase 2
$Xencor(XNCR.US)$ Phase 2
$Harmony Biosciences(HRMY.US)$ Phase 2
$Alnylam Pharmaceuticals(ALNY.US)$ Phase 2
$Disc Medicine(IRON.US)$ Phase 2
$Atea Pharmaceuticals(AVIR.US)$ Phase 2
$Allakos(ALLK.US)$ Phase 2...
i) Current market- $SPDR S&P 500 ETF(SPY.US)$
ii) Oil price
iii) My trade based on stage analysis
i) To be honest, after the last month CPI showed that the inflation is still not under controlled, the big sell off volume ha...
No comment yet